Advanced non-viral gene delivery systems are expanding the range of indications and therapy modalities possible for the new generation of genetic medicines.

A study by IRB Barcelona reveals that transfer RNA (tRNA) genes accumulate mutations at a frequency up to nine times higher ...

A study finds tRNA genes are mutation hotspots that alter protein synthesis, leading to proteome instability, contributing to ...

Creative Biogene, a frontrunner in biotechnology solutions, providing cost-effective consumables and reagents, focusing on first generation as well as next-generation sequencing and DNA fragment ...

The right approaches are demonstrating that it is possible to breach the defensively designed blood-brain barrier despite its ...

Solid Biosciences delivers its largest scientific program at the 2026 ASGCT Annual Meeting with 5 oral presentations and 11 ...

Not every animated series from the 1970s appeals to audiences in the 2020s, but these 10 should still capture your attention ...

Genetic research in Parkinson disease (PD) and related disorders has advanced significantly in recent years, primarily through large-scale genome-wide ...

Human systems immunology is using multi-omics, single-cell tools, spatial technologies, and AI to decode immune responses ...

Short-term nutritional state can reshape T cell metabolism, with post-meal lipid metabolism enhancing T cell metabolic ...

Apertura Gene Therapy, a biotechnology company developing next-generation AAV capsids for delivering genetic medicines, along with scientists from the Broad Institute of MIT and Harvard, will present ...

Increasingly complex cell therapy modalities, including multi-edit knock-in/knockout designs, are accelerating adoption of ...